Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
265.00    3.50 (1.34%)
Bid:
260.00
Ask:
270.00
Spread: 10.00 (3.846%)
Market Cap: £240.73m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Update

2 Sep 2015 09:05

RNS Number : 7570X
Concurrent Technologies PLC
02 September 2015
 

02 September 2015

Concurrent Technologies Plc

 

Product Update

Next generation 3U VPXTM board featuring newly launched processor

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce the launch of their first single board computer, a TR E5x/msd, based on the new Intel® Xeon® processor E3 family.

 

The TR E5x/msd features a quad core Intel® Xeon® processor with up to 16 Gbytes of DRAM and a rich assortment of I/O interfaces. With further improved processing and graphics performance and a wider range of configuration options than previous products, the TR E5x/msd is particularly suited to high-end multi-processor applications such as Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance applications within the defence market which is an important contributor to the Company's revenues. The product is expected to appeal to both existing and new customers within the defence market as well as the aerospace and transportation markets.

 

Initial shipments of air-cooled variants will be followed by rugged conduction-cooled modules, once the necessary qualifications are complete, ensuring this product will appeal to applications within both benign and harsh environments.

 

Glen Fawcett, CEO, Concurrent Technologies Plc, commented:

"We are excited to introduce our first new generation Intel® Xeon® processor based board. We are committed to delivering high quality embedded computers utilising the latest processors from Intel to advance our Size, Weight and Power (SWAP) propositions. The VPX form-factor is a popular choice and the new board complements our existing range of processor boards, switches, mass storage, I/O expansion carriers and development systems to provide a straightforward path from prototype to deployment."

 

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, CEO

 

+44 (0)1206 752 626

Newgate (Financial PR)Tim Thompson

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Neil McDonald

Nick Tulloch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using mainly Intel® processors, including the latest generation Intel® Core™ i7 processors, Intel® Xeon® and Intel® Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments. Other processors now include NVIDIA® Tegra® K1 devices.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLLBMATMBTMBAA
Date   Source Headline
5th Nov 20207:00 amRNSLaunch of high performance Advanced MC Board
21st Oct 20204:02 pmRNSTreasury Shares
20th Oct 20209:07 amRNSTreasury Shares
16th Oct 20207:00 amRNSIssue of Share Options and PDMR dealing
16th Oct 20207:00 amRNSTreasury Shares
6th Oct 20204:50 pmRNSTotal Voting Rights
11th Sep 20203:07 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSInterim Results
21st Aug 20207:00 amRNSNotification of Interim Results
23rd Jul 202011:15 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSRetirement of Director
17th Jun 20202:33 pmRNSResult of AGM
16th Jun 20202:45 pmRNSAGM Statement
9th Jun 20205:17 pmRNSTotal Voting Rights & Director Shareholding
1st Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSHolding(s) in Company
27th May 20204:55 pmRNSTotal Voting Rights & Director Shareholding
22nd May 20202:34 pmRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Appointment
12th May 20207:00 amRNSTotal Voting Rights
30th Apr 20206:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSResults for the year ended 31 December 2019
17th Apr 20207:00 amRNSNotice of Results
26th Mar 20207:00 amRNSDirector Appointment and Results Timing Update
10th Mar 20207:00 amRNSSecond Interim Dividend
14th Feb 20206:06 pmRNSDirector/PDMR Shareholding
12th Feb 202012:18 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSProduct Announcement
24th Jan 20204:29 pmRNSHolding(s) in Company
21st Jan 20207:00 amRNSPost-Close Trading Update
7th Jan 20202:13 pmRNSHolding(s) in Company
7th Jan 20202:10 pmRNSHolding(s) in Company
6th Jan 202012:29 pmRNSHolding(s) in Company
20th Nov 201910:14 amRNSHolding(s) in Company
11th Oct 20191:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
9th Aug 20197:00 amRNSNotice of Interim Results
11th Jun 20198:45 amRNSProduct Announcement
22nd May 20194:41 pmRNSResult of AGM
21st May 20192:30 pmRNSAGM Statement
8th May 20197:00 amRNSDeath of Director
24th Apr 20197:00 amRNSDistribution of Annual Report and Accounts
4th Apr 20197:00 amRNSResults for the year ended 31 December 2018
29th Mar 20197:00 amRNSNotice of Results
14th Mar 20197:00 amRNSSecond Interim Dividend
6th Mar 20197:00 amRNSProduct Announcement
17th Jan 20192:50 pmRNSPost-Close Trading Update
14th Jan 20192:00 pmRNSLeave of Absence
8th Oct 20187:00 amRNSProduct Announcement
12th Sep 20187:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.